The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Krause B. J., Souvatzoglou M., Tuncel M., Herrmann K., Buck A. K., Praus C., ...Daha Fazla

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.35, sa.1, ss.18-23, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 1
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1007/s00259-007-0581-4
  • Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.18-23
  • Anahtar Kelimeler: prostate cancer, PET, PET, CT, PET oncology, POSITRON-EMISSION-TOMOGRAPHY, RADICAL PROSTATECTOMY, LOCAL RECURRENCE, RADIATION-THERAPY, COMPUTED-TOMOGRAPHY, C-11-CHOLINE PET, ANTIGEN RELAPSE, DISEASE, RADIOTHERAPY, EXPERIENCE
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose An increase of the serum PSA-level is a sensitive in vitro marker for recurrent prostate cancer. However, it remains difficult to differentiate between local, regional or distant recurrent disease. The aim of this study was to assess the relationship between the detection rate of [C-11]Choline-PET/CT and the serum PSA-level in patients with a biochemical recurrence of prostate cancer with the view towards localisation of recurrent disease.